The best Side of "3
Other clinical trials in individuals with non-Hodgkin's lymphoma [24] and individuals with Highly developed malignancy [fourteen] have shown also that zosuquidar didn't significantly impact the pharmacokinetics of doxorubicin and had moderate consequences to the pharmacokinetics of vincristine. These medical trials accredited that zosuquidar could